...WenLong Gu; Chunyan Yi; Xueqing Yu; Xiao Yang Background/Aims: Metabolic syndrome (MS) has been widely proved as a predictor of cardiovascular disease, all-cause, and cardiovascular mortality in general population. But its effects on mortality and technique failure have not been well illustrated...

...Hwee-Yeong Ng; Yueh-Ting Lee; Wei-Hung Kuo; Pei-Chen Huang; Wei-Chia Lee; Chien-Te Lee Background/Aims: Hyperglycemia and hyperuricemia are two major disorders of Metabolic syndrome. Kidney plays a crucial role in maintaining the homeostasis of uric acid and glucose. The aim of the study...

...Mark D. DeBoer; Stephanie L. Filipp; Solomon K. Musani; Mario Sims; Mark D. Okusa; Matthew Gurka Background/Aims: The metabolic syndrome (MetS), as assessed using dichotomous criteria, is associated with increased risk of future chronic kidney disease (CKD), though this relationship is unclear...

... population are associated with enhanced risk of metabolic syndrome with abdominal obesity, type 2 diabetes, hypertension, coronary artery disease, heart failure, vascular dementia, cognitive impairment, microalbuminuria, chronic kidney disease, inflammatory bowel disease, cancer, and premature mortality...

..., instructions or products referred to in the content or advertisements. Periodontitis Urinary albumin/creatinine ratio Metabolic syndrome Diabetes mellitus Original Paper Kidney Blood Press Res 2017;42:338-346 DOI: 10.1159/000477784 © 2017 The Autho©r(s2)0. 1P7ubTlhiseheAdutbhyoSr(.sK) arger AG...

... renal disease but also affects mortality and cardiovascular outcomes caused by hypertension. To help understand the pathogenesis and early prevention of progressive CKD, this large-scale study is designed to determine the complex association between serum uric acid (SUA), metabolic syndrome...

... as a predictor of chronic kidney disease (CKD) and metabolic syndrome (MS), using BIA. Methods: We identified 24,791 adults who underwent voluntary routine health checkups at Yeungnam University Hospital. In total 22,480 patients were recruited into our study. Participants were divided into 3 tertiles based...

... Sleep apnea syndrome Metabolic syndrome Hypertension poses growing challenge for health policy-makers and doctors worldwide. It has been estimated that 26% of the population was hypertensive in 2000 and this percentage is bound to increase to almost 30% by 2025 [ 1 ]. The history...

...Mohamed Shafiu; Richard J. Johnson; Stephen T. Turner; Taimour Langaee; Yan Gong; Arlene B. Chapman; John G. Gums; Julie A. Johnson Background/Aims: Hyperuricemia is associated with obesity and the metabolic syndrome. URAT1 is a urate transporter, and we tested the association of URAT1 transporter...

... open-label study to assess the influence of 6 months’ atorvastatin therapy on plasma concentrations of some adipokines in patients with metabolic syndrome. Subjects: 36 adult patients with metabolic syndrome and serum LDL cholesterol >3.5 mmol/l, previously untreated with statins, were included...

... for the renoprotective effects of pioglitazone in diabetes additional to glycemic control. Diabetic nephropathy Thiazolidinediones Peroxisome proliferator-activated receptor-γ Metabolic syndrome Fibrosis Inflammation ZDF fa/fa rat Nitric oxide synthase VEGF Megalin 5 01 2010 18 08 2010 11...

...Hossein Fakhrzadeh; Maryam Ghaderpanahi; Farshad Sharifi; Zohre Badamchizade; Mojde Mirarefin; Bagher Larijani Background: To explore the interrelationship between metabolic syndrome (MS), chronic kidney disease (CKD) and C-reactive protein (CRP) in an elderly Iranian cohort. Methods: 122 residents...

...Maria Pietrzak-Nowacka; Krzysztof Safranow; Elżbieta Byra; Agnieszka Bińczak-Kuleta; Andrzej Ciechanowicz; Kazimierz Ciechanowski Background: The aim of this work was to compare the prevalence of the metabolic syndrome (MS) and its components between a group of autosomal-dominant polycystic kidney...

...Altan Onat; Gülay Hergenç; Hüseyin Uyarel; Hakan Özhan; A. Metin Esen; Ahmet Karabulut; Sinan Albayrak; Günay Can; Ibrahim Keleş Aims: The association of mild renal dysfunction (estimated glomerular filtration rate [eGFR] 60–89.9 ml/min/1.73 m 2 ) with insulin resistance (IR) or metabolic syndrome...

...Omer Toprak; Mustafa Cirit; Murat Yesil; Daniel W. Byrne; Nursen Postaci; Serdar Bayata; Karen M. Majchrzak; Ertap Esi Background/Aims: Metabolic syndrome (MS) as a risk factor for contrast-induced nephropathy (CIN) has not been studied. The aim of the present study was to assess the influence...